As a national leader in integrated healthcare services, Encompass Health offers both facility-based and home-based patient care through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies. With a national footprint that includes 137 hospitals, 241 home health locations, and 82 hospice locations in 39 states and Puerto Rico, the Company provides high-quality, cost-effective integrated healthcare. Encompass Health is ranked as one of Fortune's 100 Best Companies to Work For.

Company profile
Ticker
EHC
Exchange
Website
CEO
Mark Tarr
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
HEALTHSOUTH CORP, HEALTHSOUTH REHABILITATION CORP
SEC CIK
Corporate docs
Subsidiaries
A&B Home Health Solutions, LLC • Abba Home Health, L.P. • Advanced Homecare Management, Inc. • AHM Action Home Health, LP • AnMed Encompass Health Rehabilitation Hospital, LLC • Apex Hospice LLC • Best Home Care LP • Camellia Home Health of Alabama, LLC • Camellia Home Health of East Tennessee, LLC • Camellia Home Health of the Gulf Coast, LLC ...
IRS number
630860407
EHC stock data
News

Bullish Friday For Marijuana Stocks - Leviathan Natural Prods, Item 9 Labs Among Top Gainers
24 Jun 22
Bullish Tuesday For Marijuana Stocks - Sundial Growers, Item 9 Labs Among Top Gainers
21 Jun 22
Truist Securities Maintains Buy on Encompass Health, Lowers Price Target to $75
21 Jun 22
Stephens & Co. Maintains Overweight on Encompass Health, Lowers Price Target to $74
21 Jun 22
Cannabis Stock Gainers And Losers From June 17, 2022
17 Jun 22
Press releases
ENCOMPASS HEALTH CELEBRATES LAUNCHING ITS 150TH HOSPITAL WITH ORACLE CERNER EHR
20 Jun 22
Encompass Health and NCH Healthcare System announce plan to own and operate inpatient rehabilitation hospital in Naples, Florida
15 Jun 22
Encompass Health Corporation Board of Directors Declares Distribution of Enhabit Home Health & Hospice
14 Jun 22
Encompass Health issues full-year 2022 guidance for Encompass Health and Enhabit
7 Jun 22
Encompass Health Rehabilitation Hospital of Cape Coral, a 40-bed inpatient rehabilitation hospital, now open
1 Jun 22
Analyst ratings and price targets
Current price
Average target
$76.60
Low target
$70.00
High target
$82.00
Truist Securities
Maintains
$75.00
Stephens & Co.
Maintains
$74.00
Raymond James
Maintains
$70.00
Credit Suisse
Maintains
$82.00
RBC Capital
Maintains
$82.00
Calendar
3 May 22
26 Jun 22
31 Dec 22
Financial summary
Quarter (USD) | Mar 22 | Dec 21 | Sep 21 | Jun 21 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 21 | Dec 20 | Dec 19 | Dec 18 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 155.2M | 155.2M | 155.2M | 155.2M | 155.2M | 155.2M |
Cash burn (monthly) | (no burn) | 11.76M | (no burn) | (no burn) | (no burn) | (no burn) |
Cash used (since last report) | n/a | 33.8M | n/a | n/a | n/a | n/a |
Cash remaining | n/a | 121.4M | n/a | n/a | n/a | n/a |
Runway (months of cash) | n/a | 10.3 | n/a | n/a | n/a | n/a |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
5 May 22 | Carmichael Greg D | Encompass Health Common Stock | Grant | Acquire A | No | No | 0 | 2,226 | 0 | 7,173 |
5 May 22 | Chidsey John | Encompass Health Common Stock | Grant | Acquire A | No | No | 0 | 2,226 | 0 | 127,420 |
5 May 22 | Katz Leslye G | Encompass Health Common Stock | Grant | Acquire A | No | No | 0 | 2,226 | 0 | 33,867 |
5 May 22 | Correll Donald L | Encompass Health Common Stock | Grant | Acquire A | No | No | 0 | 2,226 | 0 | 79,447 |
Institutional ownership, Q1 2022
0.0% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 1 |
Opened positions | 1 |
Closed positions | 1 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 0 |
Total shares | 1 |
Total puts | 0 |
Total calls | 0 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Huntington National Bank | 1 | $0 |
Financial report summary
?Risks
- Quality reporting requirements could adversely affect the Medicare reimbursement we receive.
- Reimbursement claims are subject to various audits from time to time and such audits may negatively affect our operations and our cash flows from operations.
- Delays in the administrative appeals process associated with denied Medicare reimbursement claims could delay or reduce our reimbursement for services previously provided.
- Delays in collection or non-collection of our accounts receivable could adversely affect our business, financial position, results of operations and liquidity.
- Efforts to reduce payments to healthcare providers undertaken by third-party payors, conveners, and referral sources could adversely affect our revenues and profitability.
- The ongoing evolution of the healthcare delivery system, including alternative payment models and value-based purchasing initiatives, in the United States may significantly affect our business and results of operations.
- Other legislative and regulatory initiatives and changes affecting the industry could adversely affect our business and results of operations.
- Compliance with the extensive laws and government regulations applicable to healthcare providers requires substantial time, effort and expense, and if we fail to comply with them, we could suffer penalties or be required to make significant changes to our operations.
- The use of sub-regulatory guidance, statistical sampling, and extrapolation by CMS, Medicare contractors, HHS-OIG, and DOJ to deny claims, expand enforcement claims, and advocate for changes in reimbursement policy increases the risk that we could experience reduced revenue, suffer penalties, or be required to make significant changes to our operations.
- The Hospital Pricing Transparency Rule could adversely affect our business and results of operations.
- Efforts to comply with regulatory mandates to increase the use of electronic health data and health system interoperability may lead to enforcement and negative publicity which could adversely affect our business.
- If any of our hospitals or home health or hospice agencies fail to comply with the Medicare enrollment requirements or conditions of participation, that hospital or agency could be terminated from the Medicare program.
- If we are found to have violated applicable privacy and security laws and regulations or our contractual obligations, we could be subject to sanctions, fines, damages and other additional civil or criminal penalties, which could increase our liabilities, harm our reputation and have a material adverse effect on our business, financial position, results of operation and liquidity.
- The proper function, availability, and security of our information systems are critical to our business and failure to maintain proper function, availability, or security of our information systems or protect our data against unauthorized access could have a material adverse effect on our business, financial position, results of operations, and cash flows.
- We face intense competition for patients from other healthcare providers.
- If we are unable to provide a consistently high quality of care, our business will be adversely impacted.
- If we are unable to maintain or develop relationships with patient referral sources, our growth and profitability could be adversely affected.
- We may have difficulty completing investments and transactions that increase our capacity consistent with our growth strategy.
- We may make investments or complete transactions that could expose us to unforeseen risks and liabilities.
- We may not be able to successfully integrate acquisitions or realize the anticipated benefits of any acquisitions.
- Competition for staffing, shortages of qualified personnel, union activity or other factors may increase our staffing costs and reduce profitability.
- We are a defendant in various lawsuits, and may be subject to liability under qui tam cases, the outcome of which could have a material adverse effect on us.
- We may incur additional indebtedness in the future, and that debt or the associated increased leverage may have negative consequences for our business. The restrictive covenants included in the terms of our indebtedness could affect our ability to execute aspects of our business plan successfully.
- Our ability to develop adjacent service offerings for our home health and hospice business is subject to a number of risks.
Management Discussion
- During the three months ended March 31, 2022, Net operating revenues increased 8.4% over the same period of 2021 due primarily to volume and pricing growth in our inpatient rehabilitation segment. See “Results of Operations” and the “Segment Results of Operations” sections of this Item for additional volume and pricing information.
- We continued our development and expansion efforts in 2022. In our inpatient rehabilitation segment we:
- •began operating our new 40-bed inpatient rehabilitation hospital in St. Augustine, Florida in March 2022;
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. junior Avg
|
New words:
agency, agreed, Augustine, BJC, Boise, builder, commencement, comment, consent, contingent, continuum, distribute, distribution, diversified, docket, employment, Enhabit, greater, Henry, high, Idaho, IRS, leader, letter, Libertyville, LLC, Marble, people, privacy, publish, rebranded, rebranding, receipt, recommended, registration, requisite, resume, resumed, Saint, Shiloh, similar, spin, St, stockholder, supplemental, supplemented, thereto, transfer, travel, twelfth, Virginia, volatility, Williamsburg
Removed:
Alabama, Alaska, American, anxiety, appeal, ASC, assisted, assurance, ASU, avoid, bank, BCA, begin, captioned, Choice, circuit, closing, Colorado, compensatory, Congressional, Coralville, Dakota, deliver, delivered, Demonstration, denominator, EHC, EHHI, emotional, enacted, entered, examination, exercised, FASB, guidance, HealthSouth, heightened, ill, implemented, incentive, indirect, individual, investor, Iowa, Jefferson, judgment, legislation, living, lock, mandatory, matter, misrepresent, Montana, motion, noncurrent, November, NYSE, Ohio, OMB, overstate, package, pain, partial, partially, PAYGO, plaintiff, present, punitive, ramping, renewed, representing, repurchased, Rescue, retrospective, scheme, settled, settling, Shannon, Simplifying, Sioux, spending, spiritual, standard, sustained, symptom, taxing, technical, terminally, Toledo, Topic, transition, treasury, unrecognized, vested, visitation, waive, Washington, Wyoming, York
Financial reports
Current reports
8-K
Regulation FD Disclosure
21 Jun 22
8-K
Regulation FD Disclosure
13 Jun 22
8-K
Entry into a Material Definitive Agreement
7 Jun 22
8-K
Encompass Health issues full-year 2022 guidance for Encompass Health and Enhabit
7 Jun 22
8-K
Submission of Matters to a Vote of Security Holders
9 May 22
8-K
Encompass Health reports results for first quarter 2022
27 Apr 22
8-K
Encompass Health appoints Kevin O’Connor to its Board of Directors
31 Mar 22
8-K
Regulation FD Disclosure
16 Mar 22
8-K
Results of Operations and Financial Condition
1 Feb 22
8-K
Entry into a Material Definitive Agreement
25 Jan 22
Registration and prospectus
424B5
Prospectus supplement for primary offering
30 Sep 20
FWP
Free writing prospectus
30 Sep 20
424B5
Prospectus supplement for primary offering
30 Sep 20
S-3ASR
Automatic shelf registration
20 Sep 20
424B5
Prospectus supplement for primary offering
14 May 20
FWP
Free writing prospectus
12 May 20
POSASR
Automatic shelf registration (post-effective amendment)
12 May 20
424B5
Prospectus supplement for primary offering
11 May 20
424B5
Prospectus supplement for primary offering
11 Sep 19
FWP
Free writing prospectus
9 Sep 19
Proxies
DEFA14A
Additional proxy soliciting materials
26 Mar 21
DEFA14A
Additional proxy soliciting materials
10 Apr 20
DEFA14A
Additional proxy soliciting materials
27 Mar 20
DEFA14A
Additional proxy soliciting materials
21 Mar 19
DEF 14A
Definitive proxy
22 Mar 18
DEFA14A
Additional proxy soliciting materials
22 Mar 18
Other
UPLOAD
Letter from SEC
2 Jul 17
CORRESP
Correspondence with SEC
29 Jun 17
UPLOAD
Letter from SEC
25 Jun 17
EFFECT
Notice of effectiveness
4 Feb 16
CORRESP
Correspondence with SEC
2 Feb 16
UPLOAD
Letter from SEC
31 Jan 16
CORRESP
Correspondence with SEC
28 Jan 16
CERTNYS
Certification of approval for NYSE listing
27 Dec 15
CT ORDER
Confidential treatment order
14 Jun 15
UPLOAD
Letter from SEC
24 Mar 15
Ownership
3
Initial statement of insider ownership
17 Jun 22
4
Encompass Health / Terrance Williams ownership change
9 May 22
4
Encompass Health / Christopher R Reidy ownership change
9 May 22
4
Encompass Health / Kevin J. O'Connor ownership change
9 May 22
4
Encompass Health / LESLYE G KATZ ownership change
9 May 22
4
Encompass Health / DONALD L CORRELL ownership change
9 May 22
4
Encompass Health / JOHN CHIDSEY ownership change
9 May 22
4
Encompass Health / GREG D CARMICHAEL ownership change
9 May 22
4
Encompass Health / JOAN E HERMAN ownership change
8 May 22
4
Encompass Health / Patricia Anne Maryland ownership change
8 May 22
Transcripts
2022 Q1
Earnings call transcript
30 Apr 22
2021 Q4
Earnings call transcript
2 Feb 22
2021 Q3
Earnings call transcript
28 Oct 21
2021 Q2
Earnings call transcript
29 Jul 21
2021 Q1
Earnings call transcript
28 Apr 21
2020 Q4
Earnings call transcript
27 Jan 21
2020 Q3
Earnings call transcript
1 Nov 20
2020 Q3
Earnings call transcript
1 Nov 20
2020 Q3
Earnings call transcript
1 Nov 20
2020 Q2
Earnings call transcript
28 Jul 20
Reddit threads
Daily Discussion Thread - April 27th, 2022
27 Apr 22
Daily Discussion Thread - April 26th, 2022
26 Apr 22
Daily Discussion Thread - April 25th, 2022
25 Apr 22
Daily Discussion Thread - March 31st, 2022
31 Mar 22
Daily Discussion Thread - March 30th, 2022
30 Mar 22
Daily Discussion Thread - March 29th, 2022
29 Mar 22
Daily Discussion Thread - March 28th, 2022
28 Mar 22
Daily Discussion Thread - February 1st, 2022
1 Feb 22
Daily Discussion Thread - January 31st, 2022
31 Jan 22
Daily Discussion Thread - December 31st, 2021
31 Dec 21